Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Decision making in abuse potential assessments… are we getting it right?

With Dr Andy Mead, Director of Drug Abuse Liability and Substance Use Disorders, Sygnature Discovery

Getting abuse potential assessments right is critical, achieving the right balance between minimising risk to society from drug abuse, while ensuring patients’ access to beneficial new treatments. But are we getting it right?

View Webinar

Webinar Data Capture

Latest Webinars

View All

Degraders on The Rise – Targeted Protein…

Psychedelics and Psychiatry: A Roadmap to Evaluate…

A Tale of Two Libraries: How can…

Mouse Models of Cancer: understand their limitations…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.